Therapeutic: eblasakimab for atopic dermatitis
Therapeutic: anticancer agent repotrectinib
Therapeutic: capivasertib as an anticancer agent
Shimadzu and the drive for automation
Therapeutic: rozanolixizumab for generalised myasthenia gravis
Active Substances & Excipients - QP Module
Therapeutic: olutasidenib for acute myeloid leukaemia
Therapeutic: eplontersen for ATTRv-PN
IPEC Europe Annual Excipients Forum
Therapeutic: sparsentan for focal segmental glomerulosclerosis
Therapeutic: milvexian for acute coronary syndromes
Averica expands pharmaceutical impurities services
Therapeutic: garadacimab for hereditary angioedema
Therapeutic: asundexian for atrial fibrillation
Therapeutic: odronextamab for blood cancers
Assuring security of supply for phyto-APIs
Therapeutic: orismilast for psoriasis
Therapeutic: loncastuximab tesirine for diffuse large B-cell lymphoma
Therapeutic: ecopipam for Tourette syndrome
Therapeutic: zolbetuximab for gastric cancer
Therapeutic: iptacopan for paroxysmal nocturnal haemoglobinuria